Materials and Methods
Macrophage Cultures. Peritoneal leukocytes were harvested from 4-to 8-wk-old Swiss-Webster mice (13) . Nude mice were purchased from Taconic Farms, Germantown, N. Y. Cells were washed and allowed to adhere for 2 h to tissue culture dishes in medium containing penicillin, streptomycin, and 20% heat-inactivated (56°C for 30 min) fetal calf serum (FCS; Sterile Systems, Logan, Utah), as previously described (13) . Adherent cells were washed vigorously twice with Hanks' balanced salt solution (HBSS; Microbiological Associates, Walkersville, Md.). After the initial 2-h adherence, cells were assayed or incubated overnight in medium with 20% FCS and antibiotics. All solutions were free from bacterial lipopolysaceharide (LPS), as tested by the limulus amebocyte lysate assay (E-toxate; Sigma Chemical Co., St. Louis, Mo.), except that FCS contained 125 pg/ml LPS. Therefore, medium with 20% FCS contained 25 pg/ml of LPS, which is less than the minimum concentration of LPS (100 pg/ml) that we have found capable of detectably affecting macrophages overnight in vitro (11)~ Cells adherent after 2 h were >97% macrophages, as determined by examination of stained cells and by phagocytosis of Candida (14) ; after overnight culture, <1% of adherent cells were polymorphonuclear.
Determination of Cell Number. Cells adherent to culture dishes were Iysed with Zap-Ogtobin II (Coulter Diagnostics, Inc., Hialeah, Fla.). The residue was scraped off the dish with a rubber policeman, diluted 1:20 in HBSS, and nuclei were counted with a Coulter counter Model ZB (Coulter Diagnostics, Inc.). In early experiments, nuclei counts were confirmed by counting with a hemocytometer.
O~ Release. Adherent cells were washed twice with HBSS, then assayed for production of O~-measured as superoxide dismutase-inhibitable reduction of ferricytochrome c (13) . The stimulus was PMA (Consolidated Midland Corp., Brewster, N. Y.), 0.5/lg/ml. After removal of the O~ assay mixture, the cells were washed three times with HBSS; and protein was determined by the Lowry method (11) . In some experiments, three to five separate dishes were assayed for protein after washing but without addition of the O~-reaction mixture; protein contents were equivalent with the two procedures.
Enzyme Assays. N-acetyl-/~-glucosaminidase was assayed by a modification of the method of Woolen et al. (15) . Results are expressed as nanomoles ofsubstrate hydrolyzed in 1 min. Lactate dehydrogenase (LDH) was assayed by determining the rate of oxidation of reduced nicotinamide-adenine dinucleotide (Sigma Chemical Co.) at 340 nm (15) . The amount of LDH that was released into the culture supernate was expressed as the percentage of total cell LDH, determined by lysis of the cultures with 0.05% Triton X-100. I U of LDH activity was defined as a decrease in optical density of 0.001/min. (ATCC 18804) was used for phagocytosis and phagocytic killing assays, as previously described (14) . Candida (1 × 106 in 0.5 ml HBSS with 20% fresh FCS) were added to ~3 × 10 s washed cells adherent after overnight culture to 13-mm-diameter cover slips. After incubation, cover slips were washed, then double-stained with Wright's and Giemsa stains. Approximately 95% of cell-associated Candida could be seen within a detectable phagocytic vacuole (14) . Slides were coded and read without knowledge of macrophage origin.
Phagocytosis of Candida. C. albicans
The percentage of 200 macrophages that ingested one or more Candida, and the number of Candida/200 macrophages, were determined.
Phagocytosis was also studied using Candida labeled with fluorescein isothiocyanate (Calbiochem Behring Corp., American Hoechst Corp., San Diego, Cal.) (16), as described (14) .
Crystal violet, 0.5 mg/ml, abolished fluorescence of extracellular but not intracellular Candida, allowing the differentiation of ingested from attached fungi. In three comparative experiments, results at 60 min with this technique were identical to those obtained with stained cells (above)~ CandidacidalAssay. Peritoneal cells were plated on 16-mm-diameter dishes to yield equivalent numbers of adherent macrophages after overnight culture, regardless of the source of the cells, based on counts of macrophage nuclei in separate dishes and on counting cells in representative fields of the dishes to be used in the assay (14) . Macrophages were washed, then incubated with with disseminated candidiasis was grown in Sabouraud's broth for 18 h at 37°C. Candida were washed twice with HBSS and counted with a hemocytometer. Each animal was given an injection of 2 × 106 fungi into the lateral tail vein.
Injection of MDP. MDP and the D-D stereoisomer of MDP, obtained from Calbiochem-Behring Corp., were diluted in nonpyrogenic saline to a concentration of 500 #g/ml. Injections were made into the flank using a No. 26 needle. In most experiments, saline was injected as control. However, values with cells from saline controls were no different than those obtained with cells from animals given the D-D stereoisomer (as noted) or no injection. This preparation of MDP, a second MDP preparation generously given us by Dr. S. Kotani, Osaka University, Japan, and a third preparation purchased from the Pasteur Institute, Paris, when incubated in vitro with resident macrophages, primed them to an almost identical extent to release increased amounts of O~-when stimulated with PMA (11) . All MDP solutions were negative for LPS by the limulus assay (11) . The MDP obtained from Calbiochem-Behring Corp., at concentrations of 5 and 30 p,g/ml, did not activate the alternative pathway during incubation for 15 or 30 rain in either pooled human serum or serum from Swiss-Webster mice, using a sensitive kinetic hemolytic assay (17) . Phenol-extracted LPS (11), 30 p,g/ml, vigorously activated the alternative pathway in both types of sera. MDP, 5 and 30/~g/ml, also did not activate the classical pathway in human serum when incubated at 37°C for 30 min, using antibody-coated sheep erythrocytes in the same kinetic system.
Results
Macrophage Spreading, Protein Content, and Enzyme Activities. Table I summarizes the effects of injection of MDP on certain properties of peritoneal macrophages that have been associated previously with macrophage activation (13, (18) (19) (20) . Macrophages from MDP-treated mice showed enhanced spreading during 2 h of adherence, increased protein content, greater total cell activity of the lysosomal hydrolase flglucosaminidase, and increased total cell activity of LDH. fl-glucosaminidase re- * Mice were injected subcutaneously with 25-1130 #g MDP or saline ~ 18 h before collecting cells from the peritoneal cavity. After incubation on dishes for 2 h, nonadherent cells were washed away, and the adherent cells were studied as described. Cells studied for fi-glucosaminidase and LDH activities were from mice given 100 #g MDP. :~ Mean ± SEM. Number of paired experiments is given in parentheses in the MDP column. Each experiment was performed with cells pooled from 2-10 mice, and tested in duplicate or triplicate. Results were significantly greater with cells from MDP-treated mice (P < 0.01 for protein content, P < 0.001 for the other three variables, paired t test). § Elongated cells had a length:width ratio of >1.5, as detected with phase-contrast microscopy (11) . mained significantly higher in cells from MDP-treated mice after 24 or 48 h in culture (five expei, iments). Release of LDH, an indicator of cell death, was equivalent in the two cell populations after culture for 24 and 48 h (n --5). Treatment of mice with MDP also increased the number of peritoneal cells obtained -18 h later (3.6 -+ 0.3 and 5.7 ± 0.2 X 106 cells/mouse for control and MDP-treated mice, respectively; mean ± SEM for six pools of cells). The percentage of these cells that adhered to culture dishes as macrophages was equivalent in the two groups of mice (-30%, n = 7).
In view of the possible relationship of macrophage stimulation by MDP to the adjuvanticity of this compound (3), additional experiments were performed testing the effects of injection of the D-D stereoisomer of MDP, which is inactive as an adjuvant. In two paired experiments, results with macrophages pooled from six to eight mice given D-D MDP were almost identical to those with macrophages from saline-injected animals for each of the four variables of Table I and for the number of peritoneal cells obtained per mouse. Results with cells from animals given saline were equivalent in these experiments and the paired experiments of Table I .
Generation of 0~. Macrophages obtained from inflammatory exudates or from
BCG-infected mice, or macrophages incubated with MDP in vitro, are primed to release greater amounts of O~-when stimulated with PMA than are resident cells (11, 13) . MDP, 25-100 ~g administered subcutaneously 18 h before macrophage harvesting, primed peritoneal macrophages to produce up to five times moreO~-than control macrophages produced ( Fig. 1) . A dose of 50 ~g MDP was employed to evaluate the time course of the O~-effect ( Fig. 2 ). Some enhancement in PMA-stimulated O~release was noted 1 h after injection. The enhanced O~-response reached optimal levels by 3 h after MDP injection and remained at such levels for at least 48 h.
The results shown in Figs. 1 and 2 were obtained with macrophages allowed to adhere for 2 h; in six experiments with mice given 50 ~g MDP 18 h before macrophage harvest, the release of O~-from macrophages cultured overnight was almost identical to release from macrophages stimulated after 2-h adherence (645 ± 67 and 651 + 49 nmol/mg, respectively). Injection of the D-D stereoisomer of MDP did not prime peritoneal macrophages for enhanced O~-response (165 ± 20 nmol/mg, compared with 148 ± 12 nmol/mg for control cells; n --2).
We explored the question of whether MDP might act directly on the macrophage or whether it interacts with lymphocytes to cause production of lymphokines, which would, in turn, activate the macrophages. Nude mice (nu/nu, on Swiss-Webster background), which lack mature T cells, were pretreated with MDP in varying amounts. Normal littermates (nu/S/W) were used as controls. Fig. 3 shows that both nu/nu mice and littermates responded in a similar fashion to MDP, suggesting that mature T-cell function is not essential for the MDP-mediated enhancement of O~ release.
Phagocytosis and Killing of Candida. The capacity of control and MDP-treated macrophages to ingest Candida was compared. As noted in Fig. 4 A, at all time points a slightly higher percentage of macrophages from MDP-treated mice were phagocytic, and MDP macrophages ingested slightly more Candida (Fig. 4 B) .
The killing of (2. albicans by adherent macrophages is demonstrated in Fig. 5 . Studies were performed at a ratio of ~ 1 Candida:3 macrophages in the presence of 20% fresh FCS. Under these conditions, >99% of Candida on stained cover slips were ingested by 60 rain. Crystal violet did not extinguish the fluorescence of fluorescein-labelled Candida, confirming the ingestion of all Candida by 60 rain. Candida were not easily killed by the macrophages, in agreement with the killing of only 15-36% of C. albicans by human monocytes and neutrophils (21) and rabbit peritoneal macrophages (22) .
However, macrophages from MDP-treated mice killed approximately two times more Candida than did control cells at each time point studied, and this difference was significant at each time point (P < 0.001, t test). Fig. 6B, similar results were obtained when injection of MDP immediately followed infectious challenge in 12 mice, survival being 58% by day 7. Even when MDP was given 24 h after the Candida challenge (15 mice), some protection was still observed in MDP-treated mice as compared with control mice (Fig. 6 C) .
Discussion
The designation "activated" was originally applied to macrophages obtained from animals that had enhanced ability to resist infection (19) . Biochemical, morphologic, and functional characteristics of macrophages from such animals have been described subsequently (12, 13, 18, 19) . By several of these criteria, we have demonstrated activation of mouse peritoneal macrophages after subcutaneous injection of the adjuvant MDP: Mice treated with MDP showed increased numbers of peritoneal macrophages, and when cultured, these macrophages showed more spreading and increased total cell protein. Total cellular content of the lysosomal hydrolase flglucosaminidase and of the cytoplasmic enzyme LDH was increased, as previously reported with macrophages elicited by thioglycoilate, streptococcal protein A, or protease-peptone (20) . Enhancement of the phagocytosis-associated burst of oxidative metabolism also appears to be a manifestation of macrophage activation (12, 13) . Macrophages obtained from animals infected with BCG have been shown to have increased potential for generating O~ (13) and hydrogen peroxide (12) when stimulated by phagocytosis or contact with PMA. A similar priming for enhanced O~generation was achieved by incubating MDP with mouse peritoneal macrophages in vitro (11) . In the present report, we have shown that MDP given in vivo also markedly enhanced PMA-stimulated O~-release. The absolute levels of O~-release achieved were equivalent to those obtained previously with macrophages from animals infected with BCG (13). MDP treatment enhanced phagocytosis of C. albicans only slightly. Previous studies have shown that the rate of clearance of carbon particles from the blood stream, presumably a phagocytosis-dependent event, was enhanced in MDP-treated mice (23, 24) .
The enhanced microbicidal potential of macrophages from MDP-treated animals was confirmed by direct testing. Macrophages from mice pretreated with MDP consistently killed over two times more C. albicans than did resident macrophages. This doubling of candidacidal activity is almost identical to that observed with LPSelicited or BCG-activated mouse peritoneal macrophages (14) and Freund's adjuvantelicited rabbit peritoneal macrophages (22) . The extent of killing of C. albicans by mouse macrophages is equivalent to that reported with human neutrophils or monocytes (21) .
The molecular basis for the enhanced killing capacity of MDP-activated macrophages has not been completely defined. It is unlikely that the slightly increased phagocytosis by MDP macrophages played an important part; moreover, in the candidacidal system, all candida were ingested after 60 min by both types of macrophages. We have previously reported data to suggest that the enhanced candidacidal capacity of BCG-activated and LPS-elicited macrophages is dependent on their increased oxidative metabolic response (14) , and it seems highly likely that the enhanced candidacidal activity of macrophages from MDP-treated animals results at least in part from this enhancement. Others have reported a similar association with the enhanced killing of Toxoplasma gondii (25, 26) and Trypanosoma cruzi (27) . A higher content in MDP macrophages of hydrolytic enzymes, as represented by fl-glucosaminidase, could also be relevant.
The enhanced phagocytic killing ability of macrophages from MDP-treated mice presumably played an important rote in protecting the mice against lethality from C. albicans infection, although other immunostimulatory effects of MDP also could have been involved. MDP and certain MDP analogs have been reported to protect both adult and neonatal mice challenged with lethal Klebsiella infection (24, 28) or adult mice infected with T. cruzi (29) . Direct injection into tumors of certain MDP analogs, along with trehalose dimycolate, has been associated with tumor regression in guinea pigs (30) . In contrast, 100-500 /~g of MDP given intraperitoneaUy 20 min or 5 d before infection did not protect against lethal challenge by Listeria monocytogenes (31) .
The mechanism for the rapid, apparently T-cell-independent activation of peritoneal macrophages by MDP injected at a distant site is not known. MDP did not activate complement in vitro by either the classical or alternative pathways, but stimulation of the formation or release of other humoral factors or interaction with complement components on the surface of the macrophage is possible. It is clear that MDP can induce functional changes in adherent macrophages when added to these cells in vitro (4, 5, (8) (9) (10) (11) , and vigorous efforts to exclude iymphocytes as mediators of these effects (4, 1 l) have indicated that MDP can act directly on the macrophage. Moreover, some of these changes are induced within a few hours after contact with MDP (4, 11), which is more prompt than would be expected for a lymphokinedependent effect (27) . Thus, extrapolation from these in vitro data favors a direct effect of injected MDP on the macrophage.
The experiments reported here show clearly that injection of MDP activates macrophages by morphologic, metabolic, and microbicidal criteria. These results indicate that MDP has important potential as a tool for the study of macrophage physiology. Our studies also indicate that MDP offers promise as a means of enhancing host defense. The adverse side effects of BCG and larger cell wall extracts, such as granuloma formation and adjuvant polyarthritis (3, 32) , and the potential danger from administering a viable organism like BCG, are lacking when MDP is given in saline. In fact, the only deleterious effect thus far reported with MDP has been mild pyrogenicity in rabbits (5) . The apparently direct effect of MDP on the macrophage, bypassing the T lymphocyte, suggests particular usefulness of this compound for treating the immunocompromised host.
Summary
The adjuvant muramyl dipeptide (MDP) has been shown to affect a number of macrophage functions in vitro. We studied the effect of subcutaneous injection of MDP into mice. Cultured peritoneal macrophages from treated mice displayed increased spreading, total cell protein, and specific activity of fl-glucosaminidase, a constituent of macrophage lysosomes, and of lactate dehydrogenase. Generation of superoxide anion (02) by MDP-treated macrophages stimulated by contact with phorbol myristate acetate was enhanced by over fivefold to levels achieved by macrophages from bacillus Calmette-Gu~rin-infected mice. The enhancement in stimulated 02 release was noted by 1 h after injection of MDP, peaked by 3 h, and remained high for at least 48 h. Priming for enhancement of O~-release by MDP was similar in athymic nude mice and in normal littermates, suggesting that mature T lymphocytes are not involved in this MDP effect. Priming for enhanced stimulated 02 release, and morphologic and enzymic changes, were not achieved by injection of the D-D stereoisomer of MDP. Phagocytosis of Candida albicans was only slightly greater by macrophages from mice given MDP, but MDP-stimulated cells killed two times more C. albicans in vitro than did cells from untreated animals. When MDP was given 18 h before, simultaneously with, or 24 h after lethal infectious challenge with C. albicans, treated mice were protected compared with controls. These results suggest that injection of MDP effectively and rapidly activates macrophages in the recipient animal. This agent should serve as an important probe of macrophage physiology and, perhaps ultimately, as a means of enhancing host defense in humans.
